Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.

CNS Drugs · 2017 · PMC5730627 · PMID 28980198

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

fell short of significanceno p-value reported

This ES, which would represent a large difference between two active medications, fell short of significance in the flexible-dose study.

also in 361 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.